Brief: Galecto Reports Financial Results For The Year Ended December 31, 2021
Feb 17 (Reuters) - Galecto Inc GLTO.O :
* GALECTO REPORTS FINANCIAL RESULTS FOR THE YEAR ENDED
DECEMBER
31, 2021
* GALECTO - ANTICIPATES CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL
REQUIREMENTS INTO H2 OF 2024
Source text for Eikon: ID:nGNX9p9NhD
Further company coverage: GLTO.O
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing